Generic drug producers have been handed windfall sales over the past decade. According to a new report from Morgan Stanley on the state of the generic drug industry published this week, $160 billion to $170 billion of branded sales have lost patent protection over the last ten years, and generic producers have been quick to take advantage.
- HHS Secretary Calls for Price Controls on Some Prescription Drugs
- War on Drugs Has Cost America Over $1 Trillion [INFOGRAPHIC]
This trend is expected to continue with roughly $80 billion in branded sales projected to lose patent protection over the next five years. On top of this, Morgan’s proprietary bottom-up analysis of the top 200 branded products in the US...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
